In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50.
Article
Cancer Researchers Shed Light on How Tertiary Lymphoid Structures Form
Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Pancreatic Cancer Vaccine Shows Promise in Small Trial
Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who re...
An mRNA vaccine that programs the body to fight pancreatic cancer shows early promise
Pancreatic cancer is one of the most lethal malignancies, fatal in 88% of patients. It is also one of the hardest to treat. Tumors can be surgically re...
There's Fresh Hope on One of the Toughest Cancers to Cure
Advances in personalized mRNA vaccines and AI-enabled detection are helping scientists finally make breakthroughs on pancreatic cancer. MSK's Vinod Bal...
Helping Latinos Prevent Colon Cancer: Good News about Screening
Learn from an MSK specialist in cancer care for the Latino community about screening for colorectal cancer, to help prevent the disease.
Getting closer to a vaccine for cancer
Scientists have worked for years to harness the power of the immune system. New approaches make researchers optimistic about success. MSK's Vinod Balac...
Sanjay Gupta explains how scientists are trying to 'outsmart cancer'
CNN's Dr. Sanjay Gupta reports on how scientists have found ways that mRNA vaccines may be helpful in cancer treatment. MSK's Vinod Balachandran&n...
Picking the Winners: Study Sheds Light on Possible Best Targets for Pancreatic Cancer Vaccine
Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer.
Could lab-grown organs and cancer vaccines be the future of medicine?
Lab-grown organs. AI-powered medical devices. Personalized mRNA vaccines that fight cancer. These may sound like science fiction, but the future of med...
2021 in Review: 10 Important Clinical Advances in Cancer at MSK
Learn about some of the most important clinical advances made at MSK in 2021.
Covid success of mRNA vaccines opens way to a new generation of drugs
While the mRNA vaccines made by BioNTech/Pfizer and Moderna have become synonymous with helping to dramatically reduce deaths from Covid-19, MSK's Vino...
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
In the Lab
What’s Next in Immunotherapy for Pancreatic Cancer? New Immune Cell Type May Be Key
Researchers find a potential new route to making immunotherapy work better in pancreatic cancers and possibly others.
